Results 271 to 280 of about 69,664 (311)
Some of the next articles are maybe not open access.

The Furosemide Myth

Archives of Internal Medicine, 1988
To the Editor. —In light of the interesting article by Drs Gerlag and van Meijel in the February 1988 issue of theArchives,1we would like to raise the possibility that the maximum recommended daily orally administered dose of furosemide is too low and should be raised.
Robert C. Mackow   +3 more
openaire   +3 more sources

Bumetanide and furosemide

Clinical Pharmacology and Therapeutics, 1983
We assessed the response to and handling of furosemide and bumetanide in 30 experiments with the former and 46 with the latter in normal subjects. Oral doses of furosemide (20, 40, and 80 mg) were used, and subjects received oral doses of 0.5, 1, and 2 mg bumetanide and intravenous doses of 0.5 and 1 mg bumetanide.
Ann Burdette   +4 more
openaire   +3 more sources

THE SITE OF ACTION OF FUROSEMIDE

Pharmacological Research, 1998
To establish whether furosemide (F) acts on the proximal tubule beside the thick ascending limb of Henle's loop, we reviewed the data from 55 rats studied before and during the i.v. infusion of 10 mg kg-1 of furosemide. These animals were the object of previously published studies.
ROMANO, Giulio   +3 more
openaire   +3 more sources

An HPLC Procedure for the Analysis of Furosemide in Pharmaceuticals-Analysis of Furosemide Tablets and Furosemide Injection

Analytical Letters, 1981
Abstract A simple and specific procedure was developed for the analysis of furosemide from tablets and injections. The procedure consists of extracting furosemide into aqueous sodium hydroxide, addition of the internal standard, appropriate dilution and injection onto a u Bondapak C18 reversed phase column.
Rao S. Rapaka   +2 more
openaire   +2 more sources

Deafness from Furosemide

Annals of Internal Medicine, 1970
Excerpt To the editor: In respect to the letter about deafness from furosemide in the May issue of the ANNALS(p.
M. E. Wigand, A. Heidland
openaire   +6 more sources

Pharmacodynamics and pharmacokinetics of furosemide-retard and furosemide-retard/triamterene

European Journal of Drug Metabolism and Pharmacokinetics, 1988
In a randomized cross-over study the saluretic effect of furosemide-retard was compared with the combination of furosemide-retard/triamterene in 10 healthy male volunteers. The combination led to a significantly stronger excretion of sodium and a significantly lower excretion of potassium than furosemide-retard.
V. Heimsoth, D. Loew, O. Schuster
openaire   +3 more sources

Hydralazine and furosemide kinetics

Clinical Pharmacology and Therapeutics, 1982
Fursosemide kinetics were studied in 25 patients with congestive heart failure. The elimination half-life (t1/2) was longer and the elimination rate constant and the plasma clearance smaller in patients with advanced (n = 15) than in those with moderate (n = 10) failure.
Kunihiko Katoh   +5 more
openaire   +3 more sources

Theophylline-Furosemide Inactivation?

Pediatrics, 1983
To the Editor.— A recent report by Nakagawa1 suggested a possible increased theophylline clearance when furosemide was concomitantly administered. He postulated a decreased hepatic congestion with furosemide which increased theophylline clearance. Conlon et al2 originally investigated this possible interaction but reported an increase in
Miles E. Gilman, Jamie W. Toback
openaire   +3 more sources

Diuretic Action of Furosemide

Archives of Internal Medicine, 1965
RECENTLY Kleinfelder1reported that furosemide, a new monosulfamylanthranilic acid derivative, produced a prompt diuretic response in patients with edema. Preliminary observations indicated that the diuretic action of furosemide was appreciably different from that of chlorothiazide diuretics and carbonic anhydrase inhibitors in terms of chloride ...
Duncan E. Hutcheon   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy